Form 4 · Filed Jul 6, 2026, 11:31 PM UTC
PCVX/Vaxcyte, Inc.
GUGGENHIME ANDREW — PRESIDENT AND CFO
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
4 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jul 6, 2026 | M | other | 10,000 | $5 | $53,500 | 114,395 |
| Jul 6, 2026 | S | sell | 7,913 | $57 | $452,283 | 106,482 |
| Jul 6, 2026 | S | sell | 2,087 | $58 | $120,553 | 104,395 |
| Jul 6, 2026 | M | other | 10,000 | — | — | 226,827 |
Source: SEC EDGAR raw filing ↗ · Accession 0001230724-26-000012